14 results on '"Shafer-Weaver KA"'
Search Results
2. Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status.
- Author
-
Lo B, Swafford AD, Shafer-Weaver KA, Jerome LF, Rakhlin L, Mathern DR, Callahan CA, Jiang P, Davison LJ, Stevens HE, Lucas CL, White J, von Borstel R, Todd JA, and Lenardo MJ
- Subjects
- Animals, Autoantibodies blood, Diabetes Mellitus, Type 1 pathology, Disease Progression, Female, Humans, Insulin-Secreting Cells metabolism, Mice, Mice, Inbred NOD, ROC Curve, Radioligand Assay, Reproducibility of Results, Sensitivity and Specificity, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 diagnosis, Electrochemistry methods, Insulin Antibodies blood, Insulin-Secreting Cells pathology, Luminescent Measurements methods
- Abstract
Background: The detection of insulin autoantibodies (IAA) aids in the prediction of autoimmune diabetes development. However, the long-standing, gold standard 125I-insulin radiobinding assay (RBA) has low reproducibility between laboratories, long sample processing times and requires the use of newly synthesized radiolabeled insulin for each set of assays. Therefore, a rapid, non-radioactive, and reproducible assay is highly desirable., Methods: We have developed electrochemiluminescence (ECL)-based assays that fulfill these criteria in the measurement of IAA and anti-insulin antibodies (IA) in non-obese diabetic (NOD) mice and in type 1 diabetic individuals, respectively. Using the murine IAA ECL assay, we examined the correlation between IAA, histopathological insulitis, and blood glucose in a cohort of female NOD mice from 4 up to 36 weeks of age. We developed a human IA ECL assay that we compared to conventional RBA and validated using samples from 34 diabetic and 59 non-diabetic individuals in three independent laboratories., Results: Our ECL assays were rapid and sensitive with a broad dynamic range and low background. In the NOD mouse model, IAA levels measured by ECL were positively correlated with insulitis severity, and the values measured at 8-10 weeks of age were predictive of diabetes onset. Using human serum and plasma samples, our IA ECL assay yielded reproducible and accurate results with an average sensitivity of 84% at 95% specificity with no statistically significant difference between laboratories., Conclusions: These novel, non-radioactive ECL-based assays should facilitate reliable and fast detection of antibodies to insulin and its precursors sera and plasma in a standardized manner between laboratories in both research and clinical settings. Our next step is to evaluate the human IA assay in the detection of IAA in prediabetic subjects or those at risk of type 1 diabetes and to develop similar assays for other autoantibodies that together are predictive for the diagnosis of this common disorder, in order to improve prediction and facilitate future therapeutic trials.
- Published
- 2011
- Full Text
- View/download PDF
3. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.
- Author
-
Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, Ambs S, Yagita H, and Hurwitz AA
- Subjects
- Adenocarcinoma genetics, Adenocarcinoma immunology, Adenocarcinoma metabolism, Adenocarcinoma pathology, Animals, Dendritic Cells metabolism, Dendritic Cells pathology, Forkhead Box Protein O3, Forkhead Transcription Factors antagonists & inhibitors, Forkhead Transcription Factors genetics, Gene Expression Profiling, Humans, Immune Tolerance, Lymphocyte Activation, Male, Mice, Mice, Transgenic, Prostatic Neoplasms genetics, Prostatic Neoplasms metabolism, Prostatic Neoplasms pathology, RNA, Small Interfering genetics, Signal Transduction immunology, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, T-Lymphocyte Subsets pathology, Dendritic Cells immunology, Forkhead Transcription Factors immunology, Prostatic Neoplasms immunology
- Abstract
The limited success of cancer immunotherapy is often attributed to the loss of antigen-specific T cell function in situ. However, the mechanism for this loss of function is unknown. In this study, we describe a population of tumor-associated DCs (TADCs) in both human and mouse prostate cancer that tolerizes and induces suppressive activity in tumor-specific T cells. In tumors from human prostate cancer patients and transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, TADCs expressed elevated levels of FOXO3 and Foxo3, respectively, which correlated with expression of suppressive genes that negatively regulate T cell function. Silencing FOXO3 and Foxo3 with siRNAs abrogated the ability of human and mouse TADCs, respectively, to tolerize and induce suppressive activity by T cells. Silencing Foxo3 in mouse TADCs was also associated with diminished expression of tolerogenic mediators, such as indoleamine-2,3-dioxygenase, arginase, and TGF-β, and upregulated expression of costimulatory molecules and proinflammatory cytokines. Importantly, transfer of tumor-specific CD4+ Th cells into TRAMP mice abrogated TADC tolerogenicity, which was associated with reduced Foxo3 expression. These findings demonstrate that FOXO3 may play a critical role in mediating TADC-induced immune suppression. Moreover, our results identify what we believe to be a novel target for preventing CTL tolerance and enhancing immune responses to cancer by modulating the immunosuppressive activity of TADCs found in the tumor microenvironment.
- Published
- 2011
- Full Text
- View/download PDF
4. Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.
- Author
-
Shafer-Weaver KA, Anderson MJ, Stagliano K, Malyguine A, Greenberg NM, and Hurwitz AA
- Subjects
- Animals, Antibodies immunology, CD8-Positive T-Lymphocytes transplantation, Immune Tolerance, Immunotherapy, Adoptive, Lymphocytes, Tumor-Infiltrating transplantation, Male, Mice, Mice, Transgenic, Prostatic Neoplasms therapy, T-Lymphocytes, Regulatory metabolism, Transforming Growth Factor beta metabolism, CD8-Positive T-Lymphocytes immunology, Lymphocytes, Tumor-Infiltrating immunology, Prostatic Neoplasms immunology, T-Lymphocytes, Regulatory immunology, Transforming Growth Factor beta immunology
- Abstract
We previously reported that naive, tumor-specific CD8(+) (TcR-I) T cells transferred into prostate tumor-bearing mice traffic to the prostate where they become tolerized. We now report that TcR-I cells suppress the proliferation of naive T cells. This suppression is mediated at least in part by secreted factors, and the suppressive activity can be blocked by Abs directed against TGF-beta. We further report that TcR-I cells must infiltrate the prostate to acquire suppressive activity. Delivery of tumor-specific CD4(+) T cells prevents the conversion of TcR-I cells into suppressor cells. Taken together, our findings may have critical implications for sustaining T cell responsiveness during immunotherapy, as the development of suppressor cells in the tumor microenvironment may eliminate the potency of T cells primed in the periphery or delivered during adoptive immunotherapy.
- Published
- 2009
- Full Text
- View/download PDF
5. Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.
- Author
-
Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, Greenberg NM, and Hurwitz AA
- Subjects
- Adenocarcinoma therapy, Amino Acid Sequence, Animals, Antigen-Presenting Cells immunology, CD40 Antigens antagonists & inhibitors, CD40 Antigens immunology, CD40 Ligand antagonists & inhibitors, CD40 Ligand immunology, Immune Tolerance, Immunotherapy, Adoptive, Lymph Nodes immunology, Male, Mice, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Prostatic Neoplasms therapy, Adenocarcinoma immunology, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Dendritic Cells immunology, Prostatic Neoplasms immunology
- Abstract
We reported previously that tumor-specific CD8(+) T cells (TcR-I) become tolerant in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. In this study, we show that CD4(+) TcR transgenic (TcR-II) T cells transferred into TRAMP mice became activated in lymph nodes, trafficked to the prostate, and initially functioned as T(H)1 cells. Although a single cotransfer of TcR-II cells delayed TcR-I cell tolerization, repeated transfer of TcR-II cells was required to prevent TcR-I cell tolerization and significantly slowed progression of TRAMP prostate tumors. After transfer of TcR-II cells, dendritic cells within the tumor expressed higher levels of costimulatory molecules and displayed an enhanced ability to stimulate proliferation of naive T cells. Blockade of CD40-CD40L interactions during TcR-II transfer resulted in a profound reduction in dendritic cell stimulatory capacity and a partial loss of TcR-I effector functions and tumor immunity. These data show that sustained provision of activated tumor-specific CD4(+) T cells alters the immunosuppressive tumor microenvironment, ultimately leading to the control of tumor growth. These findings will assist in the design of more effective immunotherapeutic approaches for cancer.
- Published
- 2009
- Full Text
- View/download PDF
6. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials.
- Author
-
Zaritskaya L, Shafer-Weaver KA, Gregory MK, Strobl SL, Baseler M, and Malyguine A
- Subjects
- Cancer Vaccines immunology, Cell Degranulation immunology, Clinical Trials as Topic, Cytotoxicity, Immunologic, Enzyme-Linked Immunosorbent Assay, Granzymes immunology, Humans, Melanoma immunology, Reproducibility of Results, Sensitivity and Specificity, Skin Neoplasms immunology, T-Lymphocytes, Cytotoxic immunology, Cancer Vaccines therapeutic use, Cytotoxicity Tests, Immunologic, Flow Cytometry methods, Melanoma therapy, Monitoring, Immunologic methods, Skin Neoplasms therapy
- Abstract
In this study, we evaluated the applicability of a flow cytometry-based cytotoxicity (FC) assay previously developed by our laboratory, for monitoring cancer vaccine trials. The assay simultaneously measures effector cell degranulation and target cell death. Clinically relevant samples consisted of frozen peripheral blood mononuclear cells (PBMC) from vaccinated melanoma patients with known response to the melanoma peptide g209. Both PBMC and 7 day in vitro-stimulated lymphocyte from patient samples were used as effector cells in the FC assay. Activity against the relevant g209 and the control g280 peptide measured in the FC assay was directly compared with results obtained from the Granzyme B enzyme-linked immunosorbent spot assay and the standard 51Cr-release assay run in tandem. The FC assay detected low or no activity when PBMC were used as effector cells. Using cytotoxic T lymphocytes as effector cells, little or no effector cell degranulation or cytotoxicity was measured in the FC assay in prevaccination samples. After vaccination, an increase in both degranulation and target cell death could be determined when target cells were pulsed with g209. No or low reactivity was found against g280 at any time point. Our findings exhibited excellent correlation between CD107a expression and GrB secretion and also Annexin V binding to target cells and specific lysis measured in the 51Cr-release assay. Results obtained from the FC assay were highly reproducible. Therefore, the FC assay may be applied to vaccine trial monitoring and allows the measurement of effector cell degranulation and target cell death simultaneously in a single sample.
- Published
- 2009
- Full Text
- View/download PDF
7. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity.
- Author
-
Burkett MW, Shafer-Weaver KA, Strobl S, Baseler M, and Malyguine A
- Subjects
- Annexin A5 metabolism, Antigens, CD metabolism, CD8-Positive T-Lymphocytes immunology, Cell Line, Cell Line, Tumor, Cytomegalovirus immunology, Epitopes immunology, Granzymes, Humans, Lymphocyte Depletion, Lysosomal-Associated Membrane Protein 1, Lysosomal Membrane Proteins, Peptide Fragments immunology, Serine Endopeptidases metabolism, T-Lymphocytes, Cytotoxic immunology, T-Lymphocytes, Cytotoxic metabolism, Viral Matrix Proteins immunology, Viral Proteins immunology, Cytotoxicity Tests, Immunologic methods, Flow Cytometry methods
- Abstract
Comprehensive evaluation of cell-mediated cytotoxicity is very important, especially in the clinical setting, when a surrogate immunologic endpoint that correlates with a clinical outcome needs to be defined. With the objective of simultaneously evaluating target cell death and effector cell frequency, the authors combined the measuring of the expression of the degranulation marker CD107a by effector cells with the apoptosis marker annexin V binding to target cells. Using human cytotoxic T lymphocytes, the authors found a significant incubation time-dependent increase of surface CD107a expression on effector cells due to degranulation. A parallel increase of annexin V binding to target cells due to target cell apoptosis was also found. These two parameters have shown excellent correlation in all effector/target cell systems studied. To find possible connections between effector cell degranulation (CD107a expression), granzyme B secretion, and target cell death (annexin V binding), the GrB ELISPOT assay and flow cytometric assay were performed and excellent cross-correlation was found between all three parameters. The specificity of the assay was also shown. These data show that this novel assay allows measurement of cytolytic cell activation and frequency as well as target cell death in the same sample.
- Published
- 2005
- Full Text
- View/download PDF
8. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis.
- Author
-
Lee JW, O'Brien CN, Guidry AJ, Paape MJ, Shafer-Weaver KA, and Zhao X
- Subjects
- Animals, Antibodies, Bacterial blood, Antigens, Bacterial immunology, Cattle, Emulsions, Female, Freund's Adjuvant, Immunoglobulin G biosynthesis, Lymphocytes immunology, Neutrophils immunology, Phagocytosis, Staphylococcal Infections prevention & control, Treatment Outcome, Antibodies, Bacterial biosynthesis, Bacterial Vaccines immunology, Mastitis, Bovine prevention & control, Polysaccharides, Bacterial immunology, Staphylococcal Infections veterinary, Staphylococcus aureus immunology
- Abstract
The effect of a novel bovine mastitis trivalent vaccine, containing Staphylococcus aureus capsular polysaccharide type 5 (T5), 8 (T8), and 336 (T336), on lymphocyte subpopulations, antibody production, and neutrophil phagocytosis was evaluated. Twenty pregnant heifers were immunized with either the trivalent alone, trivalent emulsified in Freund's incomplete adjuvant (FICA), trivalent in aluminum hydroxide, or adjuvant only (FICA). Immunization was done 30 d before the expected calving date followed by 2 boosts in a 2-week interval. Compared to FICA, serum antigen-specific immunoglobulin (Ig)G1 and IgG2 were significantly increased in all the vaccinated groups before parturition and sustained until 3 wk postpartum. In comparison with the trivalent alone, formulation with either adjuvant enhanced production of IgG2, but not IgG1. Immune sera, which contained the highest amount of antibodies, slightly increased neutrophil phagocytosis to the 3 serotypes of killed S. aureus, but most of the differences were not significant due to large variation between the cows. The percentage of CD4+ lymphocyte was significantly higher in vaccinated groups than that of FICA 4 wk after the primary immunization. In comparison with FICA, cows inoculated with trivalent vaccine and adjuvants had an increased percentage of CD8+ lymphocytes at 2 time points, 2 wk before and after calving. Our results indicated that the whole cell trivalent vaccine, with or without adjuvants, is able to elicit antibody responses specific to the 3 capsular polysaccharide antigens. The increase of T8-specific IgG2 was more noticeable when the vaccine was emulsified with adjuvants.
- Published
- 2005
9. Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay.
- Author
-
Shafer-Weaver KA, Sayers T, Kuhns DB, Strobl SL, Burkett MW, Baseler M, and Malyguine A
- Abstract
BACKGROUND: This study assessed the Granzyme B (GrB) ELISPOT as a viable alternative to the 51Cr-release assay for measuring cytotoxic activity of innate immune effector cells. We strategically selected the GrB ELISPOT assay because GrB is a hallmark effector molecule of cell-mediated destruction of target cells. METHODS: We optimized the GrB ELISPOT assay using the human-derived TALL-104 cytotoxic cell line as effectors against K562 target cells. Titration studies were performed to assess whether the ELISPOT assay could accurately enumerate the number of GrB-secreting effector cells. TALL-104 were treated with various secretion inhibitors and utilized in the GrB ELISPOT to determine if GrB measured in the ELISPOT was due to degranulation of effector cells. Additionally, CD107a expression on effector cells after effector-target interaction was utilized to further confirm the mechanism of GrB release by TALL-104 and lymphokine-activated killer (LAK) cells. Direct comparisons between the GrB ELISPOT, the IFN-gamma ELISPOT and the standard 51Cr-release assays were made using human LAK cells. RESULTS: Titration studies demonstrated a strong correlation between the number of TALL-104 and LAK effector cells and the number of GrB spots per well. GrB secretion was detectable within 10 min of effector-target contact with optimal secretion observed at 3-4 h; in contrast, optimal IFN-gamma secretion was not observed until 24 h. The protein secretion inhibitor, brefeldin A, did not inhibit the release of GrB but did abrogate IFN-gamma production by TALL-104 cells. GrB secretion was abrogated by BAPTA-AM (1,2-bis-(2-aminophenoxy)ethane-N,N,N', N'-tetraacetic acid tetra(acetoxymethyl) ester), which sequesters intracellular Ca2+, thereby preventing degranulation. The number of effector cells expressing the degranulation associated glycoprotein CD107a increased after interaction with target cells and correlated with the stimulated release of GrB measured in the ELISPOT assay. CONCLUSIONS: Because of its high sensitivity and ability to estimate cytotoxic effector cell frequency, the GrB ELISPOT assay is a viable alternative to the 51Cr-release assay to measure MHC non-restricted cytotoxic activity of innate immune cells. Compared to the IFN-gamma ELISPOT assay, the GrB ELISPOT may be a more direct measure of cytotoxic cell activity. Because GrB is one of the primary effector molecules in natural killer (NK) cell-mediated killing, detection and enumeration of GrB secreting effector cells can provide valuable insight with regards to innate immunological responses.
- Published
- 2004
- Full Text
- View/download PDF
10. A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.
- Author
-
Malyguine A, Strobl SL, Shafer-Weaver KA, Ulderich T, Troke A, Baseler M, Kwak LW, and Neelapu SS
- Abstract
BACKGROUND: The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells in vivo. Accordingly, immunological assays that demonstrate recognition of native tumor cells (tumor-specific) may be more clinically relevant than assays that demonstrate recognition of tumor protein or peptide (antigen-specific). METHODS: Towards this goal, we adapted the IFN-gamma ELISPOT assay to measure immune responses against autologous primary tumor cells in vaccinated cancer patients. As a model system to develop the assay, we utilized peripheral blood mononuclear cells (PBMC) directly isolated from follicular lymphoma patients vaccinated with tumor-derived idiotype protein. RESULTS: After optimizing several variables, we demonstrated that the modified IFN-gamma ELISPOT assay could be used to reliably and reproducibly determine the tumor-reactive T cell frequency in the PBMC of these patients. The precursor frequency of tumor-reactive T cells was significantly higher in the postvaccine PBMC, compared with prevaccine samples in all patients tested. Furthermore, the specificity of these T cells was established by the lack of reactivity against autologous normal B cells. CONCLUSIONS: These results demonstrate the feasibility of quantitating tumor-specific T cell responses when autologous, primary tumor cells are available as targets.
- Published
- 2004
- Full Text
- View/download PDF
11. Shifts in bovine CD4+ subpopulations increase T-helper-2 compared with T-helper-1 effector cells during the postpartum period.
- Author
-
Shafer-Weaver KA, Corl CM, and Sordillo LM
- Subjects
- Animals, Female, Immunomagnetic Separation, Interferon-gamma genetics, Interleukin-10 genetics, Interleukin-2 genetics, Interleukin-4 genetics, RNA, Messenger blood, Reverse Transcriptase Polymerase Chain Reaction, CD4 Lymphocyte Count, Cattle immunology, Postpartum Period, Th1 Cells immunology, Th2 Cells immunology
- Abstract
This study determined the cytokine profile of CD4+ T-helper cells to elucidate the specific CD4+ T-helper phenotype during the postpartum period. Peripheral blood mononuclear cells were isolated from cows during periods of increased susceptibility (3 d postpartum, n = 7) and decreased susceptibility (mid- to late lactation, n = 6) to mastitis. Isolated mononuclear cells were magnetically separated into CD4(+)-enriched or CD4(+)-depleted populations using specific bovine monoclonal antibodies and were confirmed to be enriched or depleted by flow cytometric analysis. T-helper-1 and T-helper-2 subpopulations were distinguished by cytokine profiles, at both the molecular and protein level, by competitive quantitative reverse transcriptase-polymerase chain reaction and specific bioassays, respectively. The CD4(+)-enriched cultures isolated postpartum had enhanced interleukin-4 and interleukin-10 mRNA transcript expression; cultures isolated during the mid- to late lactating period had enhanced interleukin-2 mRNA transcripts. Depletion of CD4+ lymphocytes decreased, and enrichment of CD4+ lymphocytes increased interferon-gamma transcripts in cultures isolated from mid- to late lactation cows. Interferon-gamma and interleukin-2 bioassays revealed that cytokine secretion paralleled mRNA transcript levels. These data suggest that CD4+ lymphocytes act predominantly as T-helper-2 compared with T-helper-1 within 3 d after calving. Alterations in the T-helper-1 and T-helper-2 responses, and therefore the repertoire of cytokines produced, may be an underlying reason for diminished host immune response during the postpartum period.
- Published
- 1999
- Full Text
- View/download PDF
12. Bovine CD8+ suppressor lymphocytes alter immune responsiveness during the postpartum period.
- Author
-
Shafer-Weaver KA and Sordillo LM
- Subjects
- Animals, Cattle, Cell Separation, Cell Survival immunology, Cells, Cultured, Cytotoxicity, Immunologic, Female, Humans, Immunophenotyping veterinary, Leukemia, Erythroblastic, Acute, Leukocytes, Mononuclear immunology, Lymphocyte Activation, RNA, Messenger biosynthesis, T-Lymphocytes, Regulatory metabolism, Tumor Cells, Cultured, Postpartum Period immunology, T-Lymphocytes, Regulatory immunology
- Abstract
This study examined the immunoregulatory role of CD8+ lymphocytes during the postpartum period. Peripheral blood cells were isolated from postpartum and mid to late lactating animals. Flow cytometric analysis was performed to determine the frequencies of relevant cell populations. Depletion of CD8+ lymphocytes from whole cultures significantly decreased proliferation and cytotoxic ability of cells isolated from mid to late lactating animals. Enrichment of whole cultures with CD8+ lymphocytes further decreased their proliferative ability but pure CD8+ lymphocyte had increased cytotoxic activity. In contrast, neither depletion nor enrichment of whole cultures with CD8+ lymphocytes altered the already diminished proliferative responses of cells isolated from postpartum cows. No cytotoxic activity was observed by cells isolated from postpartum animals. Cultures from mid to late lactating cows mainly expressed IFN-gamma mRNA where as IL-4 mRNA was mainly expressed by cultures isolated from postpartum animals. Flow cytometric analysis revealed that CD8+ lymphocytes have a high level of activation and expression of the beta-chain during the postpartum compared with the mid to late lactating period. These data indicate that CD8+ lymphocytes are of the suppressor compared to the cytotoxic nature immediately following parturition.
- Published
- 1997
- Full Text
- View/download PDF
13. Enhancing bactericidal activity of bovine lymphoid cells during the periparturient period.
- Author
-
Shafer-Weaver KA and Sordillo LM
- Subjects
- Animals, Cells, Cultured, Female, Flow Cytometry, Immunophenotyping, Interleukin-2 pharmacology, Labor, Obstetric, Lactation, Pregnancy, Staphylococcus aureus, Blood Bactericidal Activity, Cattle, Lymphocytes immunology
- Abstract
The antibacterial activity of bovine lymphocytes was evaluated following in vitro stimulation with interleukin-2. Mononuclear cells were isolated from the blood, lymph node, and mammary parenchymal tissue of four lactating and four periparturient dairy cows. These cells were evaluated for antibacterial activity against Staphylococcus aureus following incubation for 48 h with or without interleukin-2. Cultures stimulated with interleukin-2 had higher bactericidal activity of all three isolated cell populations than did unstimulated cultures, regardless of lactational stage. This observation suggests that this effector function may possibly be activated in vivo and may potentially increase mammary gland resistance to bacterial infections during periods of increased susceptibility. Flow cytometric analysis of the cultured cells revealed that antibacterial effector cells were mainly CD2+ and were depleted of macrophages. Despite shifts in CD4+, CD8+, and gamma delta T lymphocytes during the periparturient period, bactericidal activity was similar among the three cell sources. This similarity suggests that these lymphocyte phenotypes might not be directly responsible for this effector function. Identification of the antibacterial effector phenotype and its mechanism of action may lead to immunoregulatory strategies aimed at enhancing this novel bactericidal function.
- Published
- 1996
- Full Text
- View/download PDF
14. Diminished mammary gland lymphocyte functions parallel shifts in trafficking patterns during the postpartum period.
- Author
-
Shafer-Weaver KA, Pighetti GM, and Sordillo LM
- Subjects
- Animals, CD4-CD8 Ratio, Cattle, Cell Division, Cells, Cultured, Cytokines biosynthesis, Cytotoxicity, Immunologic, Female, Lactation immunology, Lymph Nodes cytology, Lymph Nodes immunology, Lymphocyte Count, Lymphocyte Subsets immunology, T-Lymphocytes immunology, Lymphocytes immunology, Mammary Glands, Animal immunology, Postpartum Period immunology
- Abstract
Once activated, lymphocytes can regulate both specific and nonspecific immune responses. Alterations in lymphocyte function may increase the host's vulnerability to bacterial infections such as mastitis. Susceptibility to mastitis as well as diminished leukocyte functional capabilities have been shown to be influenced by lactational stage. Therefore, the present study characterized the phenotypes and functions of several bovine lymphoid populations at two points in the lactational cycle. Mononuclear cells were isolated from peripheral blood, supramammary lymph nodes, and mammary parenchyma of mid-lactating and postpartum dairy cows. The phenotypic composition, proliferative ability, cytokine secretion, and cytotoxic activity of isolated leukocytes were assessed with respect to lactational stage and tissue source. Lower percentages of T lymphocytes were consistent with diminished mitogen-stimulated proliferation and spontaneous cytotoxic activity by lymphocytes isolated from postpartum compared with mid-lactating animals. Stimulation with interleukin-2 did not enhance the cytotoxic activity or proliferative ability of lymphocytes isolated postpartum to similar levels observed for those isolated from mid-lactating animals. These data indicate that certain diminished lymphocyte functions observed during the postpartum period may result from shifts in leukocyte trafficking patterns.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.